9th Annual Spring to Life: Gastrointestinal Cancers 2022
Target Audience
Learning Objectives
Upon completion of this activity, participants will be able to:
- Evaluate the optimal perioperative treatment approaches in the management of gastrointestinal cancers.
- Discuss updated data on novel agents and therapeutic approaches for patients with metastatic gastrointestinal cancers.
- Analyze the role of molecular biomarkers and indicated testing strategies in the care of patients with gastrointestinal malignancies.
- Discuss surgical management options of liver metastases in colorectal cancers and locoregionally advanced appendix cancer.
- Understand the role and indications of Interventional Radiologic treatment modalities in gastrointestinal malignancies.
- 8.00 AMA PRA Category 1 Credit™
- 8.00 Participation
WANT TO KNOW MORE?
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
FACULTY
New York Oncology Hematology – President
Hematologist/Medical Oncologist
NYOH Hematology Stem Cell Transplant Program
NYOH Albany Medical Center
Clinical Assistant Professor
Albany Medical College
Albany, NY
Medical Oncology - Hematology
New York Oncology Hematology
Clinical Assistant Professor
Albany Medical College
Albany, NY
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and New York Oncology Hematology, PC, and in collaboration with myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University Of Chicago Pritzker School Of Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.